Board summary
Key figures
42,223
Registered population
57.6% aged 18–64
19.4%
Aged 65+
ICB 21.9% · England 17.9%
8.8%
Ethnic minority (non-White)
4.0% Asian · England 9.6%
0.0%
In IMD quintile 1
ICB 9.2% · England 21.0%
0
Core20 residents (est.)
Resident basis; registered basis 0 · see page 3
6,235
Hypertension register
+5.72% in 3 yrs · England +5.60%
315
SMI register
22.8% of Mid Sussex's
472
COPD register
Reviews -1.63% in 3 yrs
Forecast to 2030
7,148
Hypertension patients, 2030
+913 on today
63.8%
QRISK ≥20% on statins, 2030
+2.60pp over 3 yrs
4.5%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
High-risk lipid therapy and BP trends lag.
Lipid therapy in QRISK ≥ 20% is 58.2% (England 63.6%), diabetes statin use 68.9% (England 73.2%), and BP target achievement fell 3.2% (England +3.6%).
Asthma and COPD annual reviews slipped.
Asthma reviews fell 1.8% (England +4.4%), leaving about 960 patients unreviewed, while COPD reviews fell 1.6% (England +2.8%) over 2023 to 2025.
Strong mental health physical check gains.
SMI blood pressure checks reached 84.8% (+8.4 pp vs England +4.4 pp) and alcohol recording 82.6% (+15.1 pp vs England +5.4 pp).
Population, age and ethnicity
Children comprise 23.0% of registrations alongside 8,195 patients aged 65 and over
Haywards Heath Villages PCN serves 42,223 registered patients across four practices. Children aged 0-17 comprise 23.0% of registrations (9,726 patients), above Mid Sussex (20.9%), NHS Sussex Integrated Care Board (17.7%) and England (19.6%), reaching 24.7% at Cuckfield Medical Centre. Patients aged 65+ account for 19.4% (8,195 patients), below Mid Sussex (20.0%) and the ICB (21.9%) but above England (17.9%). Based on resident Census data rather than GP lists, 91.2% identify as White (Mid Sussex 92.3%, ICB 91.0%, England 81.1%), with an 8.8% ethnic minority share including 4.0% Asian residents (Mid Sussex 3.6%, ICB 3.7%, England 9.6%).
Age profile
65+: ICB 21.9%, England 17.9%
Ethnicity
Older people · falls rows are Mid Sussex local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Mid Sussex LA) | 2,494 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 80.4% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 59.6% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Mid Sussex LA) | 1,184 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Mid Sussex LA) | 13.7 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
All practices record zero Core20 patients, with average IMD decile 8.0
The PCN average IMD decile is 8.0 (Mid Sussex 8.3, NHS Sussex Integrated Care Board 6.1, England 5.5). Across 42,223 registered patients, 0.0% (0 patients) live in national Core20 deciles (Mid Sussex 0.0%, NHS Sussex Integrated Care Board 9.2%, England 21.0%). Core20 concentration and volume are 0.0% and 0 patients across all four practices. Average IMD deciles are 7.1 at Ouse Valley Practice, 8.3 at Cuckfield Medical Centre and Lindfield Medical Centre, and 8.6 at Northlands Wood Surgery. Zero Core20 reflects national area deciles, not absent individual need.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
315
SMI register
0.74% recorded prevalence
169
Learning disability register
0.40% recorded prevalence
24
Care homes, 948 beds
In the PCN catchment
7.9%
Provide unpaid care
Mid Sussex, Census 2021
The PCN records 315 severe mental illness patients and 169 learning disability patients (0.4% prevalence, matching Mid Sussex at 0.4% but below NHS Sussex Integrated Care Board and England at 0.6%), representing 22.8% and 23.2% of borough registers respectively. Catchment care homes total 24 with 948 beds.
Severe mental illness: physical health checks
Blood pressure checks reached 84.8% (England 83.4%) and BMI recording was 83.3% (England 82.1%) for severe mental illness patients. Lindfield Medical Centre achieved 71.9% for blood pressure and 68.4% for BMI, showing uneven physical review completion.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
6,235
Hypertension register
+5.72%
Register growth, 3 yrs
Mid Sussex +5.64% · England +5.60%
+0.24pp
BP control, under 80
≤140/90 · −1.18pp aged 80+
+913
More patients by 2030
Forecast 7,148 (16.46%)
Hypertension case-finding and control
Hypertension register prevalence is 14.7% (6,235 patients), below Mid Sussex (16.1%), NHS Sussex Integrated Care Board (16.3%) and England (15.2%), though crude figures do not establish unmet need. Blood pressure recording is 91.5% (England 90.0%, Mid Sussex 91.6%). While 70.8% of hypertensive patients are treated to target (England 70.3%), achievement fell 2.4 pp or 3.2% over 2023 to 2025 (England +2.5 pp, +3.6%). Blood pressure control in patients aged 80 and over also fell 1.2 pp or 1.4% to 80.4% over 2023 to 2025 (England +1.8 pp, +2.2% to 81.2%).
Lipids and statins
Only 58.2% of patients with QRISK ≥ 20% receive lipid-lowering therapy, trailing Mid Sussex (60.0%), NHS Sussex Integrated Care Board (60.0%) and England (63.6%). Statin coverage in diabetes patients aged 40 and over without CVD is 68.9%, below England (73.2%) and Mid Sussex (70.9%).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 52,250 | £2.90 | £2.42 | £1.86 | £151,525 |
| Cardiovascular (all), 2025 | 70,538 | £3.75 | £3.32 | £3.33 | £264,518 |
In 2026, lipid-regulating drugs cost £2.90 per item across 52,250 items, above England (£1.86), Mid Sussex (£2.50) and NHS Sussex Integrated Care Board (£2.42). The PCN spends £54,340 more than at England's unit cost and £25,080 more than at the ICB unit cost, representing a cost indicator rather than an efficiency target.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−1.79%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+1.40%
Asthma prevalence, PCN 3-yr % change
The asthma register includes 2,829 patients (7.2% prevalence, England 6.6%). Annual asthma reviews fell 1.8% over 2023 to 2025 to 66.2% (England +4.4%, Mid Sussex +11.9%), leaving about 960 patients unreviewed, with Lindfield Medical Centre at 52.3% and Cuckfield Medical Centre at 76.4%. Recorded COPD prevalence is 1.1% (472 patients, England 1.9%), and annual COPD reviews fell 1.6% over 2023 to 2025 to 75.0% (England +2.8%, Mid Sussex +8.8%). Slower respiratory reviews could leave chronic patients without annual monitoring.
Cancer register and children's immunisation
Cancer prevalence is 4.0% (1,686 patients; England 3.8%). In childhood immunisations, 12-month 6-in-1 coverage was 91.3% (3.7 pp below the 95.0% target) and age-5 4-in-1 booster coverage was 91.6% (3.4 pp below target). Although PCN age-5 MMR2 met the 95.0% target, Ouse Valley Practice showed a 7.4 pp difference between MMR1 (96.3%) and MMR2 (88.9%). Timely pre-school booster call-recall could close coverage shortfalls before school entry.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
58.5%
Sussex ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,360
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Sussex ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 56.6% | 53.2% | 19% | 1,668 |
| Breast | 86.1% | 85.4% | 23% | 1,400 |
| Bowel | 49.8% | 47.0% | 26% | 1,133 |
| Lung | 30.3% | 33.8% | 15% | 1,058 |
| Skin cancer | 95.3% | 87.8% | 17% | 698 |
In 2022, 58.5% of cancers with a known stage (4,799 of 8,209) in NHS Sussex ICB were diagnosed at stage 1 or 2, above England (55.3%) but 16.5 pp below the 75.0% national ambition by 2028. Staged cases represented 64.3% of 12,766 registered cancers; stage data is ICB-level. Reaching 75.0% requires about 1,360 additional early diagnoses across the ICB. In Haywards Heath Villages PCN, cervical screening was 74.5% (England 66.8%), falling 1.7% over 2023 to 2025 (England -1.0%), and breast screening was 74.0% (England 69.9%). Cervical coverage was 68.3% at Northlands Wood Surgery, and fell 5.2% at Ouse Valley Practice.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In Jul 2026 (provisional), University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day referral to treatment standard (standard 85.0%), trailing Surrey and Sussex Healthcare NHS Trust (70.0%), NHS Surrey and Sussex Integrated Care Board (71.5%), England (71.2%) and Maidstone and Tunbridge Wells NHS Trust (87.4%). Faster diagnosis (28-day) was 74.0% (standard 75.0%) and 31-day treatment was 76.8% (standard 96.0%). In provider diagnostics, 12.9% waited 6+ weeks overall, with colonoscopy at 39.3% and flexi sigmoidoscopy at 45.4%. These acute provider metrics reflect trust activity rather than PCN performance.
| Pathways within standard (%) | Sussex | Surrey and Sussex Healthcare | Maidstone and Tunbridge Wells | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 74.01 | 77.74 | 81.78 | 79.29 | 79.32 |
| 31-day treatment (96%) | 76.79 | 96.20 | 98.35 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 65.20 | 69.97 | 87.43 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Sussex | Surrey and Sussex Healthcare | Maidstone and Tunbridge Wells | England |
|---|---|---|---|---|
| MRI | 5.62 | 27.53 | 0.92 | 21.40 |
| CT | 8.57 | 18.49 | 0.51 | 9.92 |
| Echocardiography | 0.39 | 43.78 | 2.57 | 28.48 |
| Colonoscopy | 39.35 | 15.11 | 19.80 | 30.83 |
| Gastroscopy | 20.02 | 21.06 | 24.03 | 29.02 |
| All 15 DM01 tests | 12.95 | 28.50 | 6.42 | 23.14 |
| Community services activity | West Sussex residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 78,050 | 309,615 |
| Referrals | 16,015 | 66,930 |
| Patients with a contact | 19,770 | 85,660 |
Community services (residents of West Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), 72.7% of community service contacts for Mid Sussex residents involved adults aged 65+ (56,740 of 78,050 contacts). These data describe borough residents' activity across all community providers, rather than direct Haywards Heath Villages PCN delivery.
Practice variation and patient experience
Phone access varies by 20.7 pp across practices despite high overall QOF achievement
In 2025/26, overall QOF achievement exceeded England (92.5%) across all four practices, from 95.9% at Ouse Valley Practice to 97.4% at Lindfield Medical Centre, with Northlands Wood Surgery at 97.1% and Cuckfield Medical Centre at 97.0%. Vaccination and immunisation achievement showed a 36.0 pp spread, from 64.0% at Ouse Valley Practice to 100.0% at Lindfield Medical Centre.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Lindfield | 146 | 0.0 | 56.5% | 71.5% | 80.5% |
| Cuckfield | 123 | 0.0 | 64.1% | 67.9% | 77.0% |
| Ouse Valley | 87 | 0.0 | 43.4% | 81.2% | 75.4% |
| Northlands Wood | 104 | 0.0 | 48.8% | 70.1% | 72.8% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
16 of 25 tracked three-year changes trail England, led by chronic review slippage
Across 25 tracked indicators over 2023 to 2025, 16 three-year changes trail England. The widest relative lags are in annual chronic reviews and blood pressure control: heart failure reviews rose +1.3% (England +8.7%), hypertension treated to target fell 3.2% (England +3.6%), asthma reviews fell 1.8% (England +4.4%), and COPD reviews fell 1.6% (England +2.8%). Conversely, physical health checks on the severe mental illness register outpaced England, with alcohol recording rising +15.1 pp to 82.6% (England +5.4 pp) and blood pressure checks rising +8.4 pp to 84.8% (England +4.4 pp).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
Hypertension treated to target
Asthma reviews
COPD reviews
BP control, 80+
Alcohol record (psychosis)
Smoking support (SMI)
BP check (SMI)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Mid Sussex | Asset | PCN | Mid Sussex |
|---|---|---|---|---|---|
| Care homes (catchment) | 24 (948 beds) | n/a | Schools (catchment) | 67 | n/a |
| Children's centres | 2 | 8 | Places of worship | 53 | 95 |
| Libraries | 1 | 4 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | 1 | 2 | Carers support groups (VCS) | n/a | 1 |
| Primary schools (LA maintained) | 7 | 19 | Primary academies | 14 | 22 |
| Special schools | 1 | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Cardiovascular lipid and BP titration
QRISK ≥ 20% lipid therapy is 58.2% (England 63.6%); hypertension control fell 3.2% (-2.4 pp; England +3.6%, +2.5 pp); 52,250 lipid items cost £54,340 more than at England's £1.86 unit cost. Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 2
Respiratory annual review and recall
Asthma reviews fell 1.8% to 66.2% (England +4.4%), leaving about 960 of 2,829 patients unreviewed (Lindfield Medical Centre 52.3%); COPD reviews fell 1.6% to 75.0% (England +2.8%). For discussion: practices could standardise respiratory recall templates, offer flexible review slots, and audit records for uncoded COPD. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 3
SMI and learning disability outreach
At Lindfield Medical Centre, SMI BP checks are 71.9% (PCN 84.8%) and BMI 68.4% (PCN 83.3%); the 169-patient learning disability register (0.4% vs England 0.6%) has a +14 to +79 benchmark range. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Paediatric capacity alignment (p2) | Aged 0-17 | Medium Term Planning Framework 2026 · Neighbourhood health framework | PCN |
| Inclusion health clinical outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Physical health check recall (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension recall and titration review (p5) | Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Childhood immunisation booster recall (p6) | 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Practice telephony and triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Cardiovascular lipid and BP titration (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to target | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 2 · Respiratory annual review and recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD register | Core20PLUS5 respiratory | PCN & Practice |
| Option 3 · SMI and learning disability outreach (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope · 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
